Febbo Phillip G.

Chief Scientific & Med OfficerVERACYTE, INC. (VCYT) · full profile →Form 4 · filed Mar 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$485K
Net Open-Market Flow
-$485K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)13K$36.16$485K117K
Mar 2, 2026Tax withholding(F)6K$36.01$217K131K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001649245-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: